Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
COSCIENS Biopharma Inc. (T.CSC) had Receiveable Turnover of 1.41 for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
-2.99M |
|
-- |
|
-- |
|
-- |
|
-3.28M |
|
-- |
|
-2.97M |
|
-2.97M |
|
-2.99M |
|
-2.99M |
|
-2.99M |
|
-2.99M |
|
-3.28M |
|
-2.86M |
|
3.17M |
|
3.17M |
|
-0.94 |
|
-0.94 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
29.95M |
|
-- |
|
-- |
|
-- |
|
24.58M |
|
5.37M |
|
5.37M |
|
5.37M |
|
3.18M |
|
| Cash Flow Statement Financials | |
-11.84M |
|
-0.64M |
|
-0.57M |
|
22.91M |
|
10.21M |
|
-12.70M |
|
-0.02M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.18 |
|
-- |
|
-- |
|
0.33 |
|
0.56 |
|
34.70% |
|
-132.23% |
|
-132.23% |
|
-- |
|
-119.90% |
|
-120.41% |
|
-12.49M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
0.89 |
|
|
Receiveable Turnover |
1.41 |
63.96 |
|
-55.61% |
|
-55.61% |
|
-9.97% |
|
-36.99% |
|
1.69 |
|
-3.95 |
|
-3.74 |
|